Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
84.95 USD | +2.60% |
|
+4.57% | +6.73% |
09/07 | RBC Lifts Price Target on Axsome Therapeutics to $131 From $130, Keeps Outperform Rating | MT |
05/06 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
AXSOME THERAPEUTICS, INC. | Biopharmaceuticals | +2.60% | +4.57% | +6.73% | +15.37% | +232.23% | 403.48Cr | ![]() | ![]() | ![]() |
Technical Rankings Surperformance
- Stock Market
- Equities
- AXSM Stock
- Charts Axsome Therapeutics, Inc.
- Comparison Chart